Benzinga · Mar 5, 2026
Impact Biomedical (IBO) Stock Jumps Over 86% After Hours — Here's Why
Impact Biomedical shares jumped 86% after hours following amended merger terms with Dr Ashleys Bio Labs.
DS
AMEX · DSS
DSS, Inc.
Consumer Cyclical · Packaging & Containers
$0.65
Down-$0.04 (-5.62%)
Updated Oct 8, 2026, 11:43 PM
SID Score
3.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 9.18M
- P/E ratio
- -0.22
- Dividend yield
- 0.00%
- 52-week range
- $0.36 – $1.18
- Volume
- 22.04K
- Avg. volume
- 32.7K
Price performance · DSS
DSS price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 7, 2026
DSS closed at $0.65 after 21 trading sessions, down 13.73% for the selected period.
- Last close
- $0.65
- Period change
- -13.73%
- Period low
- $0.61
- Period high
- $0.78
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 7, 2026 | $0.6032 | $0.65 | $0.6032 | $0.647 | 22.04K |
| Oct 6, 2026 | $0.60 | $0.6474 | $0.60 | $0.629 | 16.52K |
| Oct 5, 2026 | $0.623 | $0.65 | $0.6146 | $0.6146 | 36.12K |
| Oct 2, 2026 | $0.6511 | $0.6674 | $0.6213 | $0.6378 | 31.93K |
| Oct 1, 2026 | $0.65 | $0.65 | $0.6247 | $0.65 | 36.2K |
| Sep 30, 2026 | $0.662 | $0.6668 | $0.64 | $0.64 | 38.14K |
| Sep 29, 2026 | $0.7238 | $0.7238 | $0.668 | $0.682 | 23.59K |
| Sep 28, 2026 | $0.6855 | $0.70 | $0.671 | $0.69 | 14.35K |
| Sep 25, 2026 | $0.6654 | $0.729 | $0.6654 | $0.7076 | 12.61K |
| Sep 24, 2026 | $0.6948 | $0.7051 | $0.6602 | $0.677 | 29.65K |
| Sep 23, 2026 | $0.6913 | $0.7292 | $0.6822 | $0.6948 | 15.81K |
| Sep 22, 2026 | $0.7092 | $0.7299 | $0.676 | $0.7127 | 104.13K |
| Sep 21, 2026 | $0.693 | $0.77 | $0.693 | $0.7385 | 136.1K |
| Sep 18, 2026 | $0.691 | $0.74 | $0.6903 | $0.7011 | 103.29K |
| Sep 17, 2026 | $0.721 | $0.7698 | $0.7142 | $0.7199 | 36.66K |
| Sep 16, 2026 | $0.701 | $0.748 | $0.701 | $0.7432 | 104.66K |
| Sep 15, 2026 | $0.739 | $0.7692 | $0.7328 | $0.7411 | 56.49K |
| Sep 14, 2026 | $0.7035 | $0.762 | $0.6845 | $0.762 | 58.56K |
| Sep 11, 2026 | $0.7528 | $0.7633 | $0.7147 | $0.7225 | 139.28K |
| Sep 10, 2026 | $0.75 | $0.80 | $0.7498 | $0.7761 | 128.52K |
| Sep 9, 2026 | $0.7603 | $0.84 | $0.71 | $0.75 | 284.97K |
Latest DSS news
The latest Smart Investors Daily articles mentioning DSS.
Stock researchCompany · Overview
Company
Market Activity
Research & News
DSS research
Overview
Company profile and research snapshot.
Company profile
DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia. Product packaging manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the securities trading and/or fund management arena.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- —
- Implied upside
- —
- Analysts
- 5
News briefing
No generated briefing is available yet.
Benzinga · Feb 5, 2026
DSS Commences ~$1M Offering Of 900K Common shares At $1/Share
DSS, Inc. (NYSE:DSS) (the "Company"), a multinational company operating across diverse industries including product packaging, biotechnology, commercial lending, and securities and investment management, today announced
Benzinga · Feb 4, 2026
DSS, Inc. Prices $1M Underwritten Public Offering Of 900,000 Common Shares At $1.00 Each
The Company expects to use the net proceeds from the offering, together with its existing cash, for general corporate purposes and working capital.
Benzinga · Feb 4, 2026
Reported Earlier, DSS Proposes Public Offering Of Common Stock, Proceeds To Support General Corporate And Working Capital Needs
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
